Skip to content
Science

DNIB.com Reports Internet Has 362.4 Million Domain Name Registrations at the End of the Second Quarter of 2024

VeriSign, Inc. 2 mins read
RESTON, Va.--BUSINESS WIRE--

VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the second quarter of 2024 closed with 362.4 million domain name registrations across all top-level domains (TLDs), unchanged compared to the first quarter of 2024. Domain name registrations increased by 5.8 million, or 1.6%, year over year.

The .com and .net TLDs had a combined total of 170.6 million domain name registrations in the domain name base at the end of the second quarter of 2024, a decrease of 1.8 million domain name registrations, or 1.1%, compared to the first quarter of 2024. The .com and .net TLDs had a combined decrease of 3.8 million domain name registrations, or 2.2%, year over year. As of June 30, 2024, the .com domain name base totaled 157.6 million domain name registrations and the .net domain name base totaled 13.0 million domain name registrations.

New .com and .net domain name registrations totaled 9.2 million at the end of the second quarter of 2024, compared to 10.2 million domain name registrations at the end of the second quarter of 2023.

Total country-code TLD (ccTLD) domain name registrations were 140.0 million at the end of the second quarter of 2024, an increase of 0.4 million domain name registrations, or 0.3%, compared to the first quarter of 2024. ccTLDs increased by 3.0 million domain name registrations, or 2.2%, year over year. The top 10 ccTLDs, as of June 30, 2024, were .cn, .de, .uk, .ru, .nl, .br, .au, .fr, .in and .eu.

Information about the statistical methodology used in creating the Domain Name Industry Brief Quarterly Report and DNIB.com’s dashboards is available here.

About DNIB.com

DNIB.com, sponsored by Verisign, provides global statistical and analytical research and data on the domain name industry, plus analyses of key policy, security, and technology trends. The latest Domain Name Industry Brief Quarterly Report, previous reports, and interactive dashboards with expanded domain name industry data are all available at DNIB.com.

About Verisign

Verisign (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, enables internet navigation for many of the world’s most recognized domain names. Verisign helps enable the security, stability, and resiliency of the Domain Name System and the internet by providing root zone maintainer services, operating two of the 13 global internet root servers, and providing registration services and authoritative resolution for the .com and .net top-level domains, which support the majority of global e-commerce. To learn more please visit verisign.com.

VRSN

© 2024 VeriSign, Inc. All rights reserved. VERISIGN, the VERISIGN logo, Domain Name Industry Brief, and other trademarks, service marks, and designs are registered or unregistered trademarks of VeriSign, Inc. and its subsidiaries in the United States and in foreign countries. All other trademarks are property of their respective owners.


Contact details:

Investor Relations: David Atchley, datchley@verisign.com, + 1 703-948-3447
Media Relations: Dave McGuire, davmcguire@verisign.com, + 1 703-948-3800

Media

More from this category

  • Biotechnology, Science
  • 23/12/2024
  • 09:00
Brandon Capital

CUREator + deploys $18.5 million in its first funding round

MELBOURNE, Australia — 23 December 2024 CUREator +, has announced that eight local startups developing innovations with the potential to save lives and improve wellbeing will receive grants totalling $18.5 million in its first funding round. CUREator+, delivered in partnership with Brandon BioCatalyst and ANDHealth, is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential. These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address unmet needs. Enabling rapid assessment of the efficacy of cancer treatments AI-powered platform providing early…

  • General News, Science
  • 19/12/2024
  • 10:00
Australian National Maritime Museum

DEEPSEA CHALLENGER returns home to Sydney in brand-new Maritime Museum exhibition

The Australian National Maritime Museum is thrilled to become the temporary home of the DEEPSEA CHALLENGER, the iconic submersible which took James Cameron to the deepest trenches of the ocean in 2012. It features within a brand-new exhibition, Ultimate Depth: A Journey to the Bottom of the Sea, opening on December 19, 2024. The DEEPSEA CHALLENGER, was designed, tested, and engineered in Sydney, was co-engineered by the renowned Ron Allum, a local Sydney cave diver, engineer, deep-sea explorer and former NSW Senior Australian of the Year. The Museum is honoured to have Ron Allum visit the exhibition for its launch…

  • Contains:
  • Engineering, Science
  • 19/12/2024
  • 09:00
UNSW Sydney

This purple diamond could one day amplify signals from deep space

They say that diamonds are a girl’s best friend – but that might also soon be true for astronomers and astrophysicists following new research…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.